{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:13:39Z","timestamp":1788401619859,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","award":["101037867"],"award-info":[{"award-number":["101037867"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijid.2026.108466","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T16:31:55Z","timestamp":1770395515000},"page":"108466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Immunogenicity, reactogenicity, and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults \u226575 years (EU-COVAT-1-AGED)\u2013final report"],"prefix":"10.1016","volume":"165","author":[{"given":"Jannik","family":"Stemler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lusine","family":"Yeghiazaryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Stephan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Greve-Isdahl Mohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca Jane","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Javier","family":"Carcas-Sansuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esperanza","family":"Romero Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Molt\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itziar","family":"Vergara Mitxeltorena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Pink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Welte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birut\u0117","family":"Zablockien\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Akova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ullrich","family":"Bethe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Salmanton-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Jakobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Tischmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marouan","family":"Zarrouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnd","family":"C\u00fcppers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena M.","family":"Biehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Grothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle C.","family":"Mellinghoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia A.","family":"Nacov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia M.","family":"Neuhann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanne","family":"Sprute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Fr\u00edas-Iniesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riya","family":"Negi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurvin","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro Garc\u00eda","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W.G.","family":"Mallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Lammens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Hotterbeekx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Loens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surbhi","family":"Malhotra-Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Goossens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Kumar-Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Posch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Koehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9599-3137","authenticated-orcid":false,"given":"Oliver A.","family":"Cornely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.108466_bib0001","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1056\/NEJMoa2114583","article-title":"Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months","volume":"385","author":"Levin","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.108466_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2020.111357","article-title":"The conundrum of human immune system ``senescence''","volume":"192","author":"Pawelec","year":"2020","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.ijid.2026.108466_bib0003","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(21)02249-2","article-title":"Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study","volume":"398","author":"Barda","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2026.108466_bib0004","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1086\/529197","article-title":"Biology of immune responses to vaccines in elderly persons","volume":"46","author":"Weinberger","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.108466_bib0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.10650","article-title":"Evaluation of waning of SARS-CoV-2 vaccine-induced immunity: a systematic review and meta-analysis","volume":"6","author":"Menegale","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijid.2026.108466_bib0006","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S1473-3099(22)00271-7","volume":"22","author":"Munro","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2026.108466_bib0007","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/S0140-6736(21)02717-3","article-title":"Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial","volume":"398","author":"Munro","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2026.108466_bib0008","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s41591-022-01739-w","article-title":"Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial","volume":"28","author":"Chu","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2026.108466_bib0009","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S1473-3099(22)00292-4","article-title":"Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort study","volume":"22","author":"Monge","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2026.108466_bib0010","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.1016\/j.vaccine.2023.10.029","article-title":"Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: a randomised VACCELERATE trial in adults \u226575 years (EU-COVAT-1)","volume":"41","author":"Neuhann","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2026.108466_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107161","article-title":"Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: a randomized VACCELERATE trial in adults aged \u226575 years (EU-COVAT-1-AGED Part B)","volume":"146","author":"Stemler","year":"2024","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2026.108466_bib0012","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1186\/s13063-022-06791-y","article-title":"A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults \u226575 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network","volume":"23","author":"Neuhann","year":"2022","journal-title":"Trials"},{"key":"10.1016\/j.ijid.2026.108466_bib0013","series-title":"Moderna Announces Preliminary Booster Data and Updates Strategy to Address Omicron Variant","year":"2021"},{"key":"10.1016\/j.ijid.2026.108466_bib0014","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1016\/j.vaccine.2022.05.022","article-title":"VACCELERATE volunteer registry: a European study participant database to facilitate clinical trial enrolment","volume":"40","author":"Salmanton-Garc\u00eda","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2026.108466_bib0015","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s40121-024-00987-2","article-title":"Immunogenicity of mRNA-1273 and BNT162b2 in immunocompromised patients: systematic review and meta-analysis using GRADE","volume":"13","author":"Kavikondala","year":"2024","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.ijid.2026.108466_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127457","article-title":"Comparison of SARS-CoV-2 antibody responses following the second dose of BNT162b2 and mRNA-1273 vaccines in people living with HIV-1","volume":"62","author":"Murata","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2026.108466_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1016927","article-title":"Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases","volume":"13","author":"Raptis","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2026.108466_bib0018","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(22)01656-7","article-title":"Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales","volume":"400","author":"Agrawal","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2026.108466_bib0019","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-24409-w","article-title":"Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years","volume":"12","author":"Durier","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2026.108466_bib0020","doi-asserted-by":"crossref","first-page":"e554","DOI":"10.1016\/S2666-7568(21)00169-0","article-title":"Immunogenicity of single vaccination with BNT162b2 or ChAdOx1 nCoV-19 at 5-6 weeks post vaccine in participants aged 80 years or older: an exploratory analysis","volume":"2","author":"Parry","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.ijid.2026.108466_bib0021","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.3390\/vaccines10091480","article-title":"Reduced antibody acquisition with increasing age following vaccination with BNT162b2: results from two longitudinal cohort studies in The Netherlands","volume":"10","author":"van den Hoogen","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijid.2026.108466_bib0022","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.cell.2022.04.009","article-title":"Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine","volume":"185","author":"Goel","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ijid.2026.108466_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1107803","article-title":"Defending against SARS-CoV-2: the T cell perspective","volume":"14","author":"Almendro-V\u00e1zquez","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2026.108466_bib0024","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3390\/vaccines9030238","article-title":"Correlates of Vaccine-Induced Protection against SARS-CoV-2","volume":"9","author":"Koch","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijid.2026.108466_bib0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jinf.2023.10.016","article-title":"The impact of vaccination and SARS-CoV-2 variants on the virological response to SARS-CoV-2 infections during the Alpha, Delta, and Omicron waves in England","volume":"88","author":"Lunt","year":"2024","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2026.108466_bib0026","doi-asserted-by":"crossref","first-page":"42","DOI":"10.24171\/j.phrp.2024.0186","article-title":"Excess mortality in older adults and cumulative excess mortality across all ages during the COVID-19 pandemic in the 20 countries with the highest mortality rates worldwide","volume":"16","author":"Chakraborty","year":"2025","journal-title":"Osong Public Health Res Perspect"},{"key":"10.1016\/j.ijid.2026.108466_bib0027","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1473-3099(22)00801-5","article-title":"Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression","volume":"23","author":"Bobrovitz","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2026.108466_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1455334","article-title":"Booster COVID-19 mRNA vaccination ameliorates impaired B-cell but not T-cell responses in older adults","volume":"15","author":"Kometani","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2026.108466_bib0029","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3390\/vaccines11071196","article-title":"Booster immunization improves memory B cell responses in older adults unresponsive to primary SARS-CoV-2 immunization","volume":"11","author":"Verheul","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijid.2026.108466_bib0031","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1007\/s15010-024-02347-1","article-title":"Innovative approaches for vaccine trials as a key component of pandemic preparedness - a white paper","volume":"52","author":"Bethe","year":"2024","journal-title":"Infection"},{"key":"10.1016\/j.ijid.2026.108466_bib0032","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1513\/AnnalsATS.202003-192SD","article-title":"The REMAP-CAP (Randomized embedded multifactorial adaptive platform for community-acquired pneumonia) study. Rationale and design","volume":"17","author":"Angus","year":"2020","journal-title":"Ann Am Thorac Soc"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226001013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226001013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T15:48:09Z","timestamp":1776095289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226001013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":31,"alternative-id":["S1201971226001013"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108466","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity, reactogenicity, and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults \u226575 years (EU-COVAT-1-AGED)\u2013final report","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108466","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108466"}}